NovaBay Pharmaceuticals' Auriclosene Irrigating Solution shows positive results in phase IIb study Sep. 20, 2016
Phase II study of CMV vaccine ASP-0113 in kidney transplant patients does not meet primary endpoint Sep. 20, 2016